Starsource Multitrade Peer Comparison

Chemo-Pharma Laboratories Ltd. is significantly underperforming compared to its peers in terms of profitability and growth metrics. The analysis reveals strong competitors like Sun Pharmaceutical Industries and Dr. Reddy's Laboratories, indicating a challenging market position for the target company. Chemo-Pharma is burdened with negative returns and no revenue growth, making it financially weak amid a robust sector.

• • Chemo-Pharma exhibits negative EPS and ROE, indicating severe financial distress.
• • Top performers like Sun Pharma and Dr. Reddy's boast solid growth and profitability metrics.
• • Valuation metrics of Chemo-Pharma suggest it is overvalued compared to its peers, lacking growth prospects.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth YoY (8.42%) and strong EPS (45.55) with solid ROE (16.13%).
• • Dr. Reddy's Laboratories Ltd.: Strong EPS growth of 68.07 and excellent profitability metrics (ROE 21.76%).